 |
|
| OCULAR THERAPEUTICS
| |
| | |
|
|
 Eye on New Discoveries
To order this title, and for more information, click here
Edited By
Thomas Yorio, University of North Texas Health Science Center, Fort Worth, Texas, USA
Abbott Clark, Alcon Laboratories, Fort Worth, Texas, USA
Martin B Wax, Alcon Laboratories, Fort Worth, Texas, USA
Description
Ocular Therapeutics: Eye on New Discovery focuses on emerging areas in ocular research, from new approaches to dry eye to gene
therapy in the management of retinal diseases. This comprehensive book features more than 25 chapters of information that will be vital
for ocular investigators and ophthalmologists bringing them new information on promising therapeutics. It is the intent of this book
to provide not only information on current approaches to treatment, but also in giving the reader a greater understanding as to what
may become available for treating a number of important eye diseases. Each chapter features some new aspect of treatment that holds great
promise for the future. The approach has been to concentrate on those areas of ocular diseases that are more prevalent. It also features
new insight for drug delivery and for managing devasting diseases, such as macula edema and glaucoma, two of the leading causes of blindness
in the United States. This book will serve as an important resource as it contains a number of relevant references highlighted for their
importance to the field. New investigators will be able to obtain an historical perspective for each of the topics and to develop an
understanding of the new research directions that are underway. Ocular Therapeutics: Eye on New Discovery is more than a reference
book, as it also provides an important glimpse into the near future.
Audience
Eye Researchers and Ophthalmologists
Contents
Section I - General Principles and Therapeutic Targets
Chapter 1: The Eye as Drug Target: Overview
Chapter 2: Drug Delivery Systems in
Ophthalmic Applications
Chapter 3: IOP as a Target - Inflow and Outflow Pathways
Chapter 4: The ciliary body: a potential multifaceted
functional neuroendocrine unit.
Chapter 5: Growth Factors and Neurotrophic Factors as Targets
Section II. Visual Pathway
Chapter 6:
New therapies for Dry Eye Disease
Chapter 7: Refractive Surgery: Corneal Opacity (haze) after Surface Ablation
Chapter 8: Progress in
Preventing Age-Related Cataract
Chapter 9: Myopia Pharmacology: Etiologic Clues, Therapeutic Potential
Section III. Inflammation, Immune
System and Anti-infectives
Chapter 10: Immune system and the eye
Chapter 11: Ocular Allergy: Clinical, Therapeutic and Drug Discovery
Considerations
Chapter 12: Ocular Inflammation in Anterior Segment
Chapter 13: Posterior Segment uveitis
Chapter 14: New Anti-Infectives
for Ophthalmology
Section IV. Clinical Therapeutics
Chapter 15: Tissue Repair and Regeneration
Chapter 16: Therapeutic Drugs for Anterior
Segment Ocular Surgery
Chapter 17: Therapeutic Drugs for Posterior Segment Vitrectomy Surgery
Chapter 18: Progress and Prospects in Ocular
Gene Therapy
Section V. Retinal Diseases and Neuropathies
Chapter 19: Neuroprotection in Glaucoma
Chapter 20: Degenerative Retinopathies
Chapter 22: Ocular Angiogenesis
Bibliographic & ordering Information
Hardbound, 536 pages, publication date: DEC-2007
ISBN-13: 978-0-12-370585-3
ISBN-10: 0-12-370585-1
Imprint: ACADEMIC PRESS
Price: Order form
GBP 86
EUR 125
USD 150
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
999/999
Last update: 26 Aug 2008
|
|
| |
| | |
|
|
| |
